Wacker and Pantherna intensify collaboration in the development and production of mRNA biopharmaceuticals
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
The agreement sets terms under which POC will manufacture the product or receive royalties
New facility is part of Aptar Pharma’s global expansion program
The €70 million investment will allow the large-scale manufacturing of high-purity reagents for quality control and testing for biopharma customers, increasing annual output by several thousand tons
Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
Nous-209 has been developed using the Nouscom's viral vector platform
Subscribe To Our Newsletter & Stay Updated